Ambu A/S (AMBBY) Research
Ambu A/S is a Danish medical technology company that develops, produces, and distributes a comprehensive range of medical devices to healthcare providers and emergency services worldwide. The firm specializes in delivering solutions across key areas such as medical visualization, anesthesia, and patient monitoring and diagnostics. Its product portfolio includes advanced endoscopy equipment, such as specialized bronchoscopes and their accompanying monitors. For neurological applications, Ambu offers EEG and EMG electrodes, instruments for EMG-guided injections, and tools for intraoperative monitoring. The company also supplies cardiology products, including various ECG electrodes. In the domain of airway management and anesthesia, Ambu's offerings span from video laryngoscopes, single and double lumen tubes, and endobronchial blockers, to laryngeal and face masks, breathing bags, and resuscitators. Additionally, they provide essential rescue and training gear like extrication collars, head immobilizers, CPR breathing barriers, and training manikins. Founded in 1937, Ambu A/S maintains its headquarters in Ballerup, Denmark.
Market snapshot
- Symbol
- AMBBY
- Price
- $9.51
- Day change
- 0.00%
- Market cap
- $16.7B
- P/E ratio
- 35.37x
- 52-week range
- 9.51-16.78
- Sector
- Healthcare
- Industry
- Medical - Devices
Peer companies
Open Ambu A/S (AMBBY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.